Xiaoqian Zhai Qiang Wu Dan Pu Liyuan Yin Weiya Wang Daxing Zhu Feng Xu
10.3389/fonc.2021.782682
Front Oncol
2022 Jan 5;11:782682.
alk fusion alk-gca and eml4-alk adjuvant targeted therapy alectinib stage iiib-n2 nsclc
CC BY
https://pubmed.ncbi.nlm.nih.gov/35070986/
Case Reports
PMC8767047
35070986
Case Report: A Novel Non-Reciprocal ALK Fusion: ALK-GCA and EML4-ALK Were Identified in Lung Adenocarcinoma, Which May Respond to Alectinib Adjuvant-Targeted Therapy
2022